Neurodegenerative Diseases: Alzheimer's disease, Parkinson's disease
Neurodegenerative Diseases: Alzheimer's disease, Parkinson's disease ( 8 Questions)
This is an incorrect answer. The caregiver does not need further teaching if they say that pramipexole will help reduce the symptoms of PD by stimulating dopamine receptors in the brain. Pramipexole is a dopamine agonist that works by mimicking the action of dopamine, which is a neurotransmitter that is deficient in PD and affects movement and cognition. Pramipexole can reduce tremors, rigidity, bradykinesia, and postural instability in clients who have PD.
This is an incorrect answer. The caregiver does not need further teaching if they say that pramipexole will help prevent the development of dyskinesia or involuntary movements in their loved one. Dyskinesia is a common side effect of levodopa-carbidopa, which is another medication used to treat PD. Pramipexole can delay or reduce the occurrence of dyskinesia by allowing lower doses of levodopa-carbidopa to be used.
This is an incorrect answer. The caregiver does not need further teaching if they say that pramipexole will help increase the duration and quality of sleep in their loved one. Sleep disturbances are common in clients who have PD, due to various factors such as nocturia, pain, restless legs syndrome, or anxiety. Pramipexole can improve sleep quality and quantity by reducing nighttime awakenings and increasing REM sleep.
This is a correct answer. The caregiver needs further teaching if they say that pramipexole will help improve the mood and motivation of their loved one. This is not the purpose or effect of pramipexole, but rather antidepressants or stimulants, which are medications used to treat depression or apathy, respectively. Depression or apathy are common neuropsychiatric symptoms of PD, which affect the levels of serotonin, norepinephrine, or dopamine in the brain.
Choice A reason:
This is an incorrect answer. The caregiver does not need further teaching if they say that pramipexole will help reduce the symptoms of PD by stimulating dopamine receptors in the brain. Pramipexole is a dopamine agonist that works by mimicking the action of dopamine, which is a neurotransmitter that is deficient in PD and affects movement and cognition. Pramipexole can reduce tremors, rigidity, bradykinesia, and postural instability in clients who have PD.
Choice B reason:
This is an incorrect answer. The caregiver does not need further teaching if they say that pramipexole will help prevent the development of dyskinesia or involuntary movements in their loved one. Dyskinesia is a common side effect of levodopa-carbidopa, which is another medication used to treat PD. Pramipexole can delay or reduce the occurrence of dyskinesia by allowing lower doses of levodopa-carbidopa to be used.
Choice C reason:
This is an incorrect answer. The caregiver does not need further teaching if they say that pramipexole will help increase the duration and quality of sleep in their loved one. Sleep disturbances are common in clients who have PD, due to various factors such as nocturia, pain, restless legs syndrome, or anxiety. Pramipexole can improve sleep quality and quantity by reducing nighttime awakenings and increasing REM sleep.
Choice D reason:
This is a correct answer. The caregiver needs further teaching if they say that pramipexole will help improve the mood and motivation of their loved one. This is not the purpose or effect of pramipexole, but rather antidepressants or stimulants, which are medications used to treat depression or apathy, respectively. Depression or apathy are common neuropsychiatric symptoms of PD, which affect the levels of serotonin, norepinephrine, or dopamine in the brain.